Statin therapy associated with 9% increase in diabetes risk Clinical study 17 January 2013 Pages: 1 - 1
The European Medicines Agency is recommending that becaplermin [Regranex] be contraindicated in patients with any pre-existing cancer, Media release 17 January 2013 Pages: 2 - 2
Products containing nimesulide are currently undergoing a full assessment by the EMA's CHMP, Media release 17 January 2013 Pages: 2 - 2
Biogen Idec and Elan have announced four new cases of progressive multifocal leukoencephalopathy (PML) in patients receiving Tysabri (natalizumab), Media release 17 January 2013 Pages: 3 - 3
Novartis Oncology have issued a letter alerting healthcare providers of new safety information, including a boxed warning, for Exjade Clinical study 17 January 2013 Pages: 4 - 4
A third collection of data on the genetic basis of drug-induced liver injury and serious skin reactions has been released, Media release 17 January 2013 Pages: 4 - 4